Key statistics
As of last trade, Actinogen Medical Ltd (3AC:FRA) traded at 0.013, 55.13% above the 52 week low of 0.0084 set on Nov 01, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.013 |
---|---|
High | 0.013 |
Low | 0.013 |
Bid | 0.013 |
Offer | 0.0175 |
Previous close | 0.0145 |
Average volume | 2.50k |
---|---|
Shares outstanding | 2.71bn |
Free float | 2.28bn |
P/E (TTM) | -- |
Market cap | 73.24m AUD |
EPS (TTM) | -0.0061 AUD |
Data delayed at least 15 minutes, as of Sep 24 2024 07:03 BST.
More ▼
Press releases
- Actinogen announces further positive results on depression in the XanCIDD phase 2a trial
- Actinogen announces achievement of clinically and statistically significant superiority of Xanamem® over placebo on depression in XanaCIDD phase 2a trial
- Positive Xanamem® biomarker trial published in the Journal of Alzheimer's Disease demonstrating potential Xanamem efficacy in patients with elevated blood pTau